Research and development (r&d) tax incentive receivable
5,240
5,054
4,529
4,132
Total current assets
80,095
74,678
78,295
19,962
Property, plant and equipment, net
47
108
168
227
Investment in joint venture
27
57
45
-
Operating lease right-of-use assets
114
163
212
258
Total assets
80,283
75,006
78,720
20,447
Trade and other payables
1,632
1,256
1,296
6,104
Accrued expenses and other current liabilities
223
181
206
696
Operating lease liabilities, current
72
110
146
184
Total current liabilities
1,927
1,547
1,648
6,984
Operating lease liabilities, non-current
42
53
64
74
Warrant liabilities
3,080
-
-
-
Total liabilities
5,049
1,600
1,712
7,058
Common stock, - par value 800,000,000 shares authorized 13,683,121 and 6,479,333 shares issued and outstanding at march 31, 2026 and june 30, 2025 respectively
41
36
35
20
Additional paid-in capital
253,216
247,042
243,837
174,049
Accumulated deficit
-174,367
-170,484
-163,963
-157,556
Foreign currency translation reserve
-3,656
-3,188
-2,901
-3,124
Total stockholders equity
75,234
73,406
77,008
13,389
Total liabilities and stockholders equity
80,283
75,006
78,720
20,447
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.